The March towards a Vaccine for Congenital CMV: Rationale and Models
Open Access
- 11 February 2016
- journal article
- pearls
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 12 (2) , e1005355
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cytomegalovirus vaccine: phase II clinical trial resultsClinical Microbiology and Infection, 2014
- A Neutralizing Anti-gH/gL Monoclonal Antibody Is Protective in the Guinea Pig Model of Congenital CMV InfectionPLOS Pathogens, 2014
- Congenital Cytomegalovirus Infection: Clinical OutcomeClinical Infectious Diseases, 2013
- Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteersVaccine, 2009
- Development of Human Cytomegalovirus–Specific T Cell Immunity during Primary Infection of Pregnant Women and Its Correlation with Virus Transmission to the FetusThe Journal of Infectious Diseases, 2007
- Preconceptual Administration of an Alphavirus Replicon UL83 (pp65 Homolog) Vaccine Induces Humoral and Cellular Immunity and Improves Pregnancy Outcome in the Guinea Pig Model of Congenital Cytomegalovirus InfectionThe Journal of Infectious Diseases, 2007
- Passive Immunization during Pregnancy for Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 2005
- A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative SubjectsThe Journal of Infectious Diseases, 2001
- A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne)The Journal of Infectious Diseases, 1999
- Antiviral Antibody Responses and Intrauterine Transmission after Primary Maternal Cytomegalovirus InfectionThe Journal of Infectious Diseases, 1995